Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study
1 other identifier
observational
100
1 country
1
Brief Summary
The main objective of the study is to evaluate the improvement in quality of life after deep brain stimulation surgery with frameless technique by comparing the PDQ-39 scale score at baseline (before surgery) and one year after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2022
CompletedFirst Submitted
Initial submission to the registry
February 21, 2023
CompletedFirst Posted
Study publicly available on registry
March 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2034
ExpectedMarch 3, 2023
February 1, 2023
1.9 years
February 21, 2023
February 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Improvement of quality of life
Evaluation of the PDQ-39 scale score at baseline (before surgery) and one year after surgery.
One year
Interventions
Clinical examinations and administration of clinical scales
Eligibility Criteria
Patients affected by Parkinson's disease and candidates to intervention of deep brain stimulation.
You may qualify if:
- diagnosis of idiopathic Parkinson's disease according to Movement Disorder Society (MDS) criteria;
- patients who are candidates for deep brain stimulation intervention, according to the international criteria of the "Core assessment program for surgical interventional therapies in Parkinson's disease" (CAPSIT-PD).
You may not qualify if:
- \- patients unable to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Flavia Torlizzi
Rome, 00168, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2023
First Posted
March 3, 2023
Study Start
January 12, 2022
Primary Completion
December 1, 2023
Study Completion (Estimated)
January 1, 2034
Last Updated
March 3, 2023
Record last verified: 2023-02